BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 1286168)

  • 1. The bcl-2 oncogene and apoptosis.
    Hockenbery DM
    Semin Immunol; 1992 Dec; 4(6):413-20. PubMed ID: 1286168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bcl-2/Bax: a rheostat that regulates an anti-oxidant pathway and cell death.
    Korsmeyer SJ; Shutter JR; Veis DJ; Merry DE; Oltvai ZN
    Semin Cancer Biol; 1993 Dec; 4(6):327-32. PubMed ID: 8142617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2.
    Strasser A; Harris AW; Bath ML; Cory S
    Nature; 1990 Nov; 348(6299):331-3. PubMed ID: 2250704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BCL-2 gene family and the regulation of programmed cell death.
    Korsmeyer SJ
    Cancer Res; 1999 Apr; 59(7 Suppl):1693s-1700s. PubMed ID: 10197582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bcl-2: an antidote to programmed cell death.
    Korsmeyer SJ
    Cancer Surv; 1992; 15():105-18. PubMed ID: 1451107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A bcl-2/IgH antisense transcript deregulates bcl-2 gene expression in human follicular lymphoma t(14;18) cell lines.
    Capaccioli S; Quattrone A; Schiavone N; Calastretti A; Copreni E; Bevilacqua A; Canti G; Gong L; Morelli S; Nicolin A
    Oncogene; 1996 Jul; 13(1):105-15. PubMed ID: 8700536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights from transgenic mice regarding the role of bcl-2 in normal and neoplastic lymphoid cells.
    Cory S; Harris AW; Strasser A
    Philos Trans R Soc Lond B Biol Sci; 1994 Aug; 345(1313):289-95. PubMed ID: 7846127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bcl-6 p53 mutations in lymphomas carrying the bcl-2/Jh rearrangement.
    Bellido M; Capello D; Altés A; Estivill C; Gaidano G; Pujol R; Bordes R; Baiget M; Saglio G; Sierra J; Nomdedéu JF
    Haematologica; 2002 Sep; 87(9):908-17. PubMed ID: 12217802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bcl-2/JH rearrangements in benign lymphoid tissues with follicular hyperplasia.
    Limpens J; de Jong D; van Krieken JH; Price CG; Young BD; van Ommen GJ; Kluin PM
    Oncogene; 1991 Dec; 6(12):2271-6. PubMed ID: 1766674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Moloney murine leukemia virus infection accelerates lymphomagenesis in E mu-bcl-2 transgenic mice.
    Shinto Y; Morimoto M; Katsumata M; Uchida A; Aozasa K; Okamoto M; Kurosawa T; Ochi T; Greene MI; Tsujimoto Y
    Oncogene; 1995 Nov; 11(9):1729-36. PubMed ID: 7478600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oligonucleotides induce apoptosis restricted to the t(14;18) DHL-4 cell line.
    Morelli S; Alama A; Quattrone A; Gong L; Copreni E; Canti G; Nicolin A
    Anticancer Drug Des; 1996 Jan; 11(1):1-14. PubMed ID: 8639245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death.
    Hockenbery D; Nuñez G; Milliman C; Schreiber RD; Korsmeyer SJ
    Nature; 1990 Nov; 348(6299):334-6. PubMed ID: 2250705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence that p53 and bcl-2 are regulators of a common cell death pathway important for in vivo lymphomagenesis.
    Marin MC; Hsu B; Meyn RE; Donehower LA; el-Naggar AK; McDonnell TJ
    Oncogene; 1994 Nov; 9(11):3107-12. PubMed ID: 7936633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival and death of prelymphomatous B-cells from N-myc/bcl-2 double transgenic mice correlates with the regulation of intracellular Ca2+ fluxes.
    Zörnig M; Busch G; Beneke R; Gulbins E; Lang F; Ma A; Korsmeyer S; Möröy T
    Oncogene; 1995 Nov; 11(10):2165-74. PubMed ID: 7478538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The functional basis of c-myc and bcl-2 complementation during multistep lymphomagenesis in vivo.
    Marin MC; Hsu B; Stephens LC; Brisbay S; McDonnell TJ
    Exp Cell Res; 1995 Apr; 217(2):240-7. PubMed ID: 7698223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The bcl-2 gene and 14;18 translocation in lymphoproliferative disorders.
    Pezzella F; Mason DY
    Nouv Rev Fr Hematol (1978); 1990; 32(6):397-9. PubMed ID: 2101872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bcl-2 antisense oligonucleotides are effective against systemic but not central nervous system disease in severe combined immunodeficient mice bearing human t(14;18) follicular lymphoma.
    Mohammad R; Abubakr Y; Dan M; Aboukameel A; Chow C; Mohamed A; Hamdy N; Al-Katib A
    Clin Cancer Res; 2002 Apr; 8(4):1277-83. PubMed ID: 11948143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bax accelerates tumorigenesis in p53-deficient mice.
    Knudson CM; Johnson GM; Lin Y; Korsmeyer SJ
    Cancer Res; 2001 Jan; 61(2):659-65. PubMed ID: 11212265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of B cell survival in xid mice by the proto-oncogene bcl-2.
    Woodland RT; Schmidt MR; Korsmeyer SJ; Gravel KA
    J Immunol; 1996 Mar; 156(6):2143-54. PubMed ID: 8690903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression in non-Hodgkin's lymphoma of the bcl-2 protein associated with the t(14;18) chromosomal translocation.
    Ngan BY; Chen-Levy Z; Weiss LM; Warnke RA; Cleary ML
    N Engl J Med; 1988 Jun; 318(25):1638-44. PubMed ID: 3287162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.